2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Leukemia, B-Cell: new trials by email Literature Review of Leukemia, B-Cell trials Research Report on Leukemia, B-Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status Cyclophosphamide, Fludarabine, Rituximab - Lymphocytic Leukemia, Chronic | Phase 4 | Terminated | Hoffmann-La Roche | 89 | 2011-06-17 | 2018-03-20 |
| A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status Chlorambucil, Cyclophosphamide, Fludarabine - Lymphocytic Leukemia, Chronic | Phase 4 | Terminated | Hoffmann-La Roche | 26 | 2011-04-27 | 2019-03-14 |
Leukemia, Lymphocytic, Chronic, B-Cell (2)
Chronic Disease (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Cyclophosphamide (2) · Rituximab (2) · fludarabine (2) · Chlorambucil (1)
Russia (2)